title: Hypertrophy decreases cardiac KATP channel responsiveness to exogenous and locally generated (glycolytic) ATP.
abstract: This study tests the hypothesis that glycolytic regulation of KATP channel activity is altered in myocardial hypertrophy. Left ventricular (LV) subendocardial myocytes were isolated from cats with normal or left ventricular hypertrophied hearts (LVH). Saponin-permeabilized open cell-attached patch configurations of normal and LVH cells were exposed to an exogenous ATP consuming system containing hexokinase and 2-deoxyglucose. Phosphoenol pyruvate (PEP, substrate for the last ATP producing step in glycolysis) was applied extracellularly; ADP was present. In both cell types, KATP channels were activated in the absence of PEP, inhibited when PEP was added and activated again when PEP was removed, indicating the cells retained metabolic integrity and generated ATP in the proximity of their KATP channels. Single channel conductance in the absence of PEP was similar (70 pS, normal; 66 pS, LVH). However, LVH KATP channels showed enhanced activity (P0=0.50+/-0.03); normal (0.41+/-0.03) in PEP absence (P<0. 05). PEP responsiveness was reduced in LVH, with IC50, PEP increased to 23 microM; (11 microM normal). Lactate failed to activate KATP channels in both cell types. The concentration-P0 response curves obtained during exposure of open cells to exogenous ATP also revealed reduced responsiveness to ATP of LVH KATP channels (IC50, ATP=283 microM LVH; 93 microM normal). Our data indicate myocardial hypertrophy increases the maximal activity of KATP channels in the absence of ATP and reduces their responsiveness to ATP, including locally generated glycolytic ATP. These alterations in metabolic regulation of myocardial electrophysiology may contribute to diversity of action potential shortening in hypertrophied hearts during acute ischemia.
authors.affiliation: Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, FL 33136, USA.
authors.forename: F
authors.initials: F
authors.lastname: Yuan
authors.forename: N R
authors.initials: NR
authors.lastname: Brandt
authors.forename: J M
authors.initials: JM
authors.lastname: Pinto
authors.forename: B J
authors.initials: BJ
authors.lastname: Wasserlauf
authors.forename: R J
authors.initials: RJ
authors.lastname: Myerburg
authors.forename: A L
authors.initials: AL
authors.lastname: Bassett
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002415:Cats; D002463:Cell Membrane Permeability; D005260:Female; D006019:Glycolysis; D017379:Hypertrophy, Left Ventricular / Q000378:metabolism*; D019344:Lactic Acid / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism*
chemical_list: D015221:Potassium Channels; D019344:Lactic Acid; D010728:Phosphoenolpyruvate; D000255:Adenosine Triphosphate